cabergoline has been researched along with Endometrial Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delgado-Rosas, F; Ferrero, H; Garcia-Velasco, J; Gaytan, F; Gómez, R; Pellicer, A; Simón, C | 1 |
| Arias, D; Corrada, Y; Gobello, C; Rodríguez, R; Tortora, M | 1 |
2 other study(ies) available for cabergoline and Endometrial Diseases
| Article | Year |
|---|---|
The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
Topics: Animals; Blood Vessels; Cabergoline; Cell Count; Cell Proliferation; Claviceps; Disease Models, Animal; Dopamine Agonists; Endometriosis; Endometrium; Ergolines; Female; Humans; Mice; Neovascularization, Pathologic; Receptors, Dopamine D2; Uterine Diseases; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Combination dopamine agonist and prostaglandin agonist treatment of cystic endometrial hyperplasia-pyometra complex in the bitch.
Topics: Animals; Cabergoline; Cloprostenol; Dog Diseases; Dogs; Dopamine Agonists; Drug Therapy, Combination; Endometrial Hyperplasia; Endometritis; Ergolines; Female; Prostaglandins, Synthetic; Ultrasonography; Uterine Diseases | 2006 |